Skip to main content
. 2022 Jun 2;14(6):386. doi: 10.3390/toxins14060386

Table 1.

Summary of ZEA-induced toxicity.

Toxic Type Animal/Cell Model Dose Exposure Time Phenotypic Modulation Pathway Reference
Reproductive toxicity Postweaning piglets 3 mg/kg bw 28 d Vulvar malformation, decreased immune response, and disorder of the level of serum hormones. Hypothalamic–pituitary–ovarian axis pathway. [43]
TM4 cells 0~30 μM 24 h TM4 cell autophagy, oxidative stress, and cytoskeletal structure destruction. PI3K/Akt/mTOR and MAPK signaling pathway. [62]
TM3 cells 50 μM 24 h Decreased cell viability and testosterone concentration, increased LDH, and cell apoptosis. PI3K/Akt, PTEN/Nrf 2/Bip, and ER-stress signaling pathway. [75]
Sertoli cells (SCs) 0~80 μM 24 h Cell cycle arrest, inhibited SCs proliferation, and cell morphological autophagy. PI3K/Akt/mTOR signaling pathway. [76]
Hepatotoxicity Balb/c mice 40 mg/kg bw 24 h Increased MDA level, protein carbonylation, SOD activity, CAT activity, and the expression level of HSP70. Oxidative stress pathway. [46]
HepG2 cells 0~100 μM 72 h Decreased cell viability and the expression of liver inflammation-related factors. Inhibit inflammatory response and liver immunity. [47]
HepG2 cells 0~40 μM 24 h Decreased cell viability, increased production of ROS, and regulated phase-I/II metabolism, resulting in autophagy and apoptosis. Oxidative stress, ER-stress, and PERK/eIF2α pathway. [49]
Immunotoxicity T lymphocytes 0~40 μM 24 h Decreased cell viability, damaged cell surface and intracellular ultrastructure of T lymphocytes, and decreased secretion of cytokines, resulting in cell apoptosis. MAPK signaling pathway, TNF-α-independent JNK signaling pathway. [53]
HL-60, U937, PBMCs 0~50 μM 24 h Decreased cell viability, increased production of ROS, and cell apoptosis. The death receptor pathway with direct involvement of caspase-8, the mitochondrial pathway, and ER-stress pathway. [35]
T lymphocytes 0~40 μM 48 h Surface and intracellular ultrastructural damage of T lymphocytes. Chemokines MIP-1α and RANTES secreted by T lymphocytes and chemokine receptor CCR2 and CCR7. [54]
T lymphocytes 0~40 μM 24 h Decreased cell viability and the expression of different activation signals in T cells inhibited the secretion of cytokines. Co-stimulatory signal and PI3K/Akt/mTOR signaling pathway. [77,78]
Genotoxicity Kunming mice 40 mg/kg bw 28 d Damaged kidney resulting in oxidative stress and renal cell apoptosis. Bip, CHOP, caspase-12, and JNK signaling pathway [59]
TM4 cells 0~100 μM 24 h Inhibited cell proliferation, cell cycle arrest, and cell apoptosis. ROS and ER stress, ATP/AMPK pathway. [61]
Carcinogenicity INS-1 cells 0~800 μM 24 h NLRP3 inflammasome activation, decreased cell viability, cell autophagy, and pyroptosis. NF-κB p65 activation and nuclear translocation. [79]
Mouse granulosa cells 10&30 μM 72 h Changed cell morphology, cell cycle arrest, and increased expression of genes related to tumorigenesis. Hippo signaling pathway. [64]
TM3 cells 0~90 μM 24 h Decreased cell viability. Ras, Rap1, PI3K/AKT, Foxo, and AMPK signaling pathway. [80]
Gastrointestinal health IPEC-J2 cells 0~80 μM 24 h Decreased the cell viability and increased LDH activity, and inhibited cell proliferation, resulting in cell cycle arrest. Pathways involved in the cell cycle G2 phase. [58]
SD mice 0~5.0 mg/kg bw 28 d Impaired intestinal barrier, increased permeability and imbalance of intestinal microbiota, and increased systematic intestinal inflammation. RhoA/ROCK signal pathway. [65]
Balb/c mice 4.5 mg/kg bw 7 d NLRP3 inflammasome activation and intestine inflammatory. NLRP3 signaling pathway. [66]
Endocrine-disrupting effects Postweaning piglets 0~3.2 mg/kg bw 18 d Inhibited LH secretion. Kisspeptin–Gpr54–GnRH Pathway. [68]
Postweaning piglets 0~1.5 mg/kg bw 35 d Inhibited follicles maturation and ovarian development. ERs/GSK-3β-dependent Wnt-1/β-catenin signaling pathway. [70]
SD mice 0~5 mg/kg bw 5 d Released gonadotropin early—resulted from the advancement of vaginal opening and enlargement of the uterus at the periphery. Hypothalamic kisspeptin–GPR54 signaling pathway. [81]